The Compound of Formula I and pharmaceutically acceptable sales thereof in the treatment of cyclooxygenase-2 mediated diseases are disclosed. ##STR1##

Das Mittel von Formel I und pharmazeutisch annehmbare Verkäufe davon in der Behandlung der cyclooxygenase-2 vermittelten Krankheiten werden freigegeben. ## STR1 ##

 
Web www.patentalert.com

< Protein HLQDR48

< Human DNase II

> Pyrazolopyridines

> 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability

~ 00069